Viewing Study NCT04396457


Ignite Creation Date: 2025-12-24 @ 6:30 PM
Ignite Modification Date: 2025-12-24 @ 6:30 PM
Study NCT ID: NCT04396457
Status: UNKNOWN
Last Update Posted: 2023-03-23
First Post: 2020-01-14
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
Sponsor:
Organization: